MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%

Sector Heatmap

Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%

SMMT — Summit Therapeutics Inc. Common Stock

Nasdaq

Summit Therapeutics Inc. Common Stock

CompareBack to Screener
$17.17
-0.78(-4.35%)
O
17.61
H
17.64
L
16.80
V
6.15M
⏱️ End-of-day dataAs of Oct 8, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About SMMT

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMar 5, 2015
Employees265
Stock ExchangeNasdaq
Ticker SymbolSMMT
Websitehttps://www.smmttx.com

Key Financial Statistics

Market Cap$13.37B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$12.07 - $29.23
52-Week Avg Volume4.20M
VWAP$17.11
Transactions59,367
Total Recorded Bars2,917 days